NCT02940496 2025-07-15
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
33 trialsNCT07038863 2025-06-26
Mondelta
Hospices Civils de Lyon
Phase NA Not yet recruiting
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT06745895 2024-12-20
MATCHES
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Recruiting
NCT04540081 2023-12-27
CLOVER
University of California, Davis
Phase NA Completed
NCT02366286 2023-12-14
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Completed
NCT05184283 2023-12-07
Utilization of MAsS in Patients Undergoing LT for HCC
Columbia University
Terminated
NCT05498779 2023-11-28
Ablation of Hepatocellular Carcinoma: a Nationwide Study
Rigshospitalet, Denmark
Completed
NCT03702998 2023-08-30
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
Completed
NCT04653818 2023-04-04
RCT
Alexandria University
Phase 4 Completed
NCT04980157 2023-01-23
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT04190498 2022-05-24
ECHAPS
University Hospital, Grenoble
Withdrawn
NCT05376943 2022-05-17
Possible Differences in HCC Course Depending on DAA Treatment
Medical University of Warsaw
Unknown
NCT02970136 2021-12-28
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
University of Miami
Phase NA Completed
NCT03200171 2021-07-21
Effect of DAAs on Behavior of HCC in HCV Patients
Al-Azhar University
Completed
NCT03254121 2021-02-18
HEPCASUS
Karolinska Institutet
Completed
NCT01821963 2020-09-24
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT04395118 2020-07-02
STOP-HCC
University of Texas Southwestern Medical Center
Phase NA Withdrawn
NCT01619475 2019-02-08
A2ALL-2
Arbor Research Collaborative for Health
Completed
NCT03775798 2018-12-19
Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.
Austral University, Argentina
Unknown
NCT02833298 2018-10-12
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT00513461 2018-08-10
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
University of California, Irvine
Phase 2 Completed
NCT00096733 2017-08-29
A2ALL-1
Arbor Research Collaborative for Health
Completed
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT00767936 2016-06-29
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford University
Terminated
NCT01831037 2015-01-28
ROLFH
University of Arkansas
Withdrawn
NCT01405183 2014-09-17
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Henry Ford Health System
Completed
NCT01729221 2012-11-20
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
Cairo University
Unknown
NCT00768001 2012-02-01
Genetic Analysis of Liver Cancer
Stanford University
Terminated
NCT01355107 2011-12-14
Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease
University Hospital Freiburg
Completed
NCT00822991 2010-12-30
Sonazoid Enhanced Liver Cancer Trial for Early Detection
Kindai University
Phase NA Unknown
NCT00273247 2006-01-09
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
National Cancer Institute, Milan
Phase 3 Completed
NCT00154531 2005-12-20
Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI
National Taiwan University Hospital
Unknown